Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.

Published

Journal Article

BACKGROUND: In an early analysis of this trial, use of a magnetically levitated centrifugal continuous-flow circulatory pump was found to improve clinical outcomes, as compared with a mechanical-bearing axial continuous-flow pump, at 6 months in patients with advanced heart failure. METHODS: In a randomized noninferiority and superiority trial, we compared the centrifugal-flow pump with the axial-flow pump in patients with advanced heart failure, irrespective of the intended goal of support (bridge to transplantation or destination therapy). The composite primary end point was survival at 2 years free of disabling stroke (with disabling stroke indicated by a modified Rankin score of >3; scores range from 0 to 6, with higher scores indicating more severe disability) or survival free of reoperation to replace or remove a malfunctioning device. The noninferiority margin for the risk difference (centrifugal-flow pump group minus axial-flow pump group) was -10 percentage points. RESULTS: Of 366 patients, 190 were assigned to the centrifugal-flow pump group and 176 to the axial-flow pump group. In the intention-to-treat population, the primary end point occurred in 151 patients (79.5%) in the centrifugal-flow pump group, as compared with 106 (60.2%) in the axial-flow pump group (absolute difference, 19.2 percentage points; 95% lower confidence boundary, 9.8 percentage points [P<0.001 for noninferiority]; hazard ratio, 0.46; 95% confidence interval [CI], 0.31 to 0.69 [P<0.001 for superiority]). Reoperation for pump malfunction was less frequent in the centrifugal-flow pump group than in the axial-flow pump group (3 patients [1.6%] vs. 30 patients [17.0%]; hazard ratio, 0.08; 95% CI, 0.03 to 0.27; P<0.001). The rates of death and disabling stroke were similar in the two groups, but the overall rate of stroke was lower in the centrifugal-flow pump group than in the axial-flow pump group (10.1% vs. 19.2%; hazard ratio, 0.47; 95% CI, 0.27 to 0.84, P=0.02). CONCLUSIONS: In patients with advanced heart failure, a fully magnetically levitated centrifugal-flow pump was superior to a mechanical-bearing axial-flow pump with regard to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device. (Funded by Abbott; MOMENTUM 3 ClinicalTrials.gov number, NCT02224755 .).

Full Text

Duke Authors

Cited Authors

  • Mehra, MR; Goldstein, DJ; Uriel, N; Cleveland, JC; Yuzefpolskaya, M; Salerno, C; Walsh, MN; Milano, CA; Patel, CB; Ewald, GA; Itoh, A; Dean, D; Krishnamoorthy, A; Cotts, WG; Tatooles, AJ; Jorde, UP; Bruckner, BA; Estep, JD; Jeevanandam, V; Sayer, G; Horstmanshof, D; Long, JW; Gulati, S; Skipper, ER; O'Connell, JB; Heatley, G; Sood, P; Naka, Y; MOMENTUM 3 Investigators,

Published Date

  • April 12, 2018

Published In

Volume / Issue

  • 378 / 15

Start / End Page

  • 1386 - 1395

PubMed ID

  • 29526139

Pubmed Central ID

  • 29526139

Electronic International Standard Serial Number (EISSN)

  • 1533-4406

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1800866

Language

  • eng

Conference Location

  • United States